22 May 2013
Keywords: neorecormon, gets, chmp, ok, anemia, switzerland-based, drug
Article | 27 November 2006
Switzerland-based drug major Roche says that the European Medicines Agency's (EMEA) Committee for Products for Human Use has recommended
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 November 2006
21 May 2013
© 2013 thepharmaletter.com